Published in AIDS Weekly, August 10th, 1998
As a partner in a new initiative to reduce mother-to-child transmission in 11 pilot countries, Glaxo-Wellcome agreed to a package that includes donation, reduced prices, and community assistance. In addition, as the global initiative expands Glaxo says it will negotiate with all interested parties.
"Glaxo's commitment is to provide differential pricing of AZT as low as three-fourths reduction of the Western price, to offer a start-up donation component in the UNAIDS/UNICEF program, and to negotiate with all interested governments and NGOs [non-government organizations],"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.